Abstract: Oral thin films are usually water-based soluble polymers designed for rapid and systematic delivery of drugs, with the active substance transported directly into the bloodstream. This avoids exposing the drug to the harsh conditions of the stomach and allows this drug delivery system to deliver a greater percentage of the active compound per dose. Oral thin films technology enables rapid release of the active substance in the form of a single or multi-layer system.Summary: Depending on the drug candidate and the targeted indication, oral thin films can be formulated as a transmucosal, in which the active substance enters the body circulation directly through the buccal mucosa, avoiding a once-through effect in the liver.References: https://www.formulationbio.com/oral-thin-films-technology-services.html
Ask the author a question about this poster.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Simulation of Rituximab and Natalizumab biomarker efficacy using simplified QSP model of B- and T- lymphocyte dynamics in Multiple Sclerosis
Anna Mishina (1,2), Tatiana Karelina (1), Evgeny Metelkin (1), Veronika Musatova (1)
Nanoparticle Development for Drug Delivery System
Drug Delivery System Development
NMR Spectrum Prediction
Heta language: Modularity and Reusability in QSP modeling platforms